Welcome to the Blog

Home  >  Blog
Child Welfare Organizations: Are You Prepared?

New York Child Victims Act Dramatically Extends Statute of Limitations New York recently passed legislation extending the statue of limitations for certain abuse victims. The Child Victims Act is likely to affect the insurance world

Read More

0
Considering Unlimited PTO? Communication is Key

Unlimited PTO is one of the latest HR innovations to improve recruitment and retention while potentially increasing productivity. It can also save substantial amounts of money by eliminating accrued vacation payouts. Competitive companies like Netflix

Read More

0
Executive Order Instructs Agencies to Expand Access to HSAs

On June 24, President Trump signed an executive order that, among other things, instructs various federal agencies to: 1) increase transparency in medical pricing and quality, 2) improve the ability of patients to control their

Read More

0
Pharmacy Cost Management: 5 Tips for Managing Your Pharmacy Benefits Partner

Now, more than ever, your pharmacy benefit manager can be a critical partner in controlling your health care costs. And, like any successful partnership, this one requires trust, transparency and goal alignment. Here are five

Read More

0
Capturing 2019 Manufacturing Opportunity: How Better Risk Management Can Strengthen Your Game

The business climate for middle-market manufacturers ($100 million to $3 billion in revenue) is growing steadily – presenting new opportunities, fresh markets and different ways of operating. That means your exposures are growing, too –

Read More

0
Tips for Balancing New Nonprofit Opportunities and Risks

How One Summer Camp Property Approached New Revenue Stream When the company producing the Tumbleweed and Dancefestopia music festivals asked about taking over the bucolic, rural Kansas Wildwood Outdoor Education Center, Executive Director Robyn Ratcliff

Read More

0
Pharmacy Cost Management: Can you benefit from recent FDA guidance on biosimilar replacements?

The U.S. Food and Drug Administration issued guidance May 13 that clears the way for pharmacists to replace some expensive biological medical products with certain biosimilars. This change has the potential to help companies save

Read More

0